1-10 of 10
Luca De Carolis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-Life Efficacy and Safety of Vemurafenib Plus Rituximab (V+R) in Relapsed or Refractory Hairy Cell Leukemia: A Multi-Center Retrospective Study (HCL-PG03R)

Enrico Tiacci, Luca De Carolis, Monia Capponi, Andrea Bernardelli, Andrea Visentin, Gianna Maria D'Elia, Simone Ferrero, Michele Cimminiello, Azzurra Anna Romeo, Barbara Pocali, Flavio Falcinelli, Alessandro Sanna, Annamaria Frustaci, Nilla Maschio, Caterina Stelitano, Jacopo Olivieri, Carlo Visco, Alessandro Pulsoni, Robin Foa, Livio Trentin, Brunangelo Falini
Journal: Blood
Blood (2023) 142 (Supplement 1): 3027.
https://doi.org/10.1182/blood-2023-178648
Published: 2023
Journal Articles

Importance of FDG-PET (Fluorodeoxyglucose Positron Emission Tomography) in Staging and Response Assessment of Hairy Cell Leukemia (HCL)

Alessandro Mancini, Luca De Carolis, Monia Capponi, Flavio Falcinelli, Edoardo Simonetti, Andrea Lupi, Jacopo Olivieri, Francesco Zaja, Matteo Porcari, Nicodemo Baffa, Brunangelo Falini, Enrico Tiacci
Journal: Blood
Blood (2023) 142 (Supplement 1): 3044.
https://doi.org/10.1182/blood-2023-177603
Published: 2023
Journal Articles

Efficacy and Safety of Obinutuzumab in Relapsed or Refractory Hairy Cell Leukemia (R/R HCL): An Italian Multicenter Phase-2 Academic Trial (HCL-PG04)

Enrico Tiacci, Luca De Carolis, Monia Capponi, Flavio Falcinelli, Francesco Zaja, Alessandro Pulsoni, Edoardo Simonetti, Elisa Montechiarello, Alessandra Romano, Jacopo Olivieri, Alessandro Mancini, Gianna Maria D'Elia, Robin Foa, Maurizio Frezzato, Brunangelo Falini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4398.
https://doi.org/10.1182/blood-2023-180035
Published: 2023
Journal Articles

How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors

Brunangelo Falini, Luca De Carolis, Enrico Tiacci
Journal: Blood
Blood (2022) 139 (15): 2294–2305.
https://doi.org/10.1182/blood.2021013502
Published: 2022
Journal Articles

The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, MD, Monia Capponi, Achille Ambrosetti, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, MD, Luigi Rigacci, Gianluca Gaidano, MD PhD, Roberta Della Seta, Natalia Frattarelli, Paolo Falcucci, Giuseppe Visani, Robin Foà, MD, Brunangelo Falini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 409.
https://doi.org/10.1182/blood.V130.Suppl_1.409.409
Published: 2017
Journal Articles

Vemurafenib Plus Rituximab in Hairy Cell Leukemia: A Promising Chemotherapy-Free Regimen for Relapsed or Refractory Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, Achille Ambrosetti, MD, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, Gianluca Gaidano, MD PhD, Robin Foà, Brunangelo Falini
Journal: Blood
Blood (2016) 128 (22): 1214.
https://doi.org/10.1182/blood.V128.22.1214.1214
Published: 2016
Journal Articles

Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Enrico Tiacci, Luca De Carolis, Pier Luigi Zinzani, Alessandro Pulsoni, Francesco Zaja, Michele Cimminiello, Achille Ambrosetti, Davide Rossi, Giovanna Motta, Marzia Varettoni, Vincenzo Fraticelli, Angelo Michele Carella, Antonella Anastasia, Pietro Leoni, Alessandro Rambaldi, Stefano Aldo Pileri, Robin Foà, Brunangelo Falini
Journal: Blood
Blood (2014) 124 (21): 150.
https://doi.org/10.1182/blood.V124.21.150.150
Published: 2014
Journal Articles

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

Vera Grossmann, Enrico Tiacci, Antony B. Holmes, Alexander Kohlmann, Maria Paola Martelli, Wolfgang Kern, Ariele Spanhol-Rosseto, Hans-Ulrich Klein, Martin Dugas, Sonja Schindela, Vladimir Trifonov, Susanne Schnittger, Claudia Haferlach, Renato Bassan, Victoria A. Wells, Orietta Spinelli, Joseph Chan, Roberta Rossi, Stefano Baldoni, Luca De Carolis, Katharina Goetze, Hubert Serve, Rudolf Peceny, Karl-Anton Kreuzer, Daniel Oruzio, Giorgina Specchia, Francesco Di Raimondo, Francesco Fabbiano, Marco Sborgia, Arcangelo Liso, Laurent Farinelli, Alessandro Rambaldi, Laura Pasqualucci, Raul Rabadan, Torsten Haferlach, Brunangelo Falini
Journal: Blood
Blood (2011) 118 (23): 6153–6163.
https://doi.org/10.1182/blood-2011-07-365320
Published: 2011
Includes: Supplemental data
Journal Articles

Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice.

Maria Paola Martelli, Valentina Pettirossi, Christian Thiede, Elisabetta Bonifacio, Mauro Di Ianni, Ilaria Gionfriddo, Debora Cecchini, Roberta Pacini, Alessia Tabarrini, Federica Mezzasoma, Roberta Rossi, Linda Giunchi, Uta Oelschlägel, Lorenzo Brunetti, Marica Gemei, Raffaella Ciurnelli, Federica Cecchetti, Luca De Carolis, Arcangelo Liso, Francesco Di Raimondo, MD, Massimo F Martelli, Brunangelo Falini, MD
Journal: Blood
Blood (2009) 114 (22): 480.
https://doi.org/10.1182/blood.V114.22.480.480
Published: 2009
Journal Articles

Acute Myeloid Leukemia with Mutated NPM1 Presenting with Life-Threatening, Either Arterial or Venous, Thromboembolism: a Report of 4 Cases.

Maria Paola Martelli, Lorenzo Brunetti, Luca De Carolis, Elisabetta Agliani, Laura Berchicci, Elisabetta Bonifacio, Valentina Pettirossi, Ilaria Gionfriddo, Debora Cecchini, Alessia Tabarrini, Roberta Rossi, Stelvio Ballanti, Massimo F Martelli, Brunangelo Falini
Journal: Blood
Blood (2009) 114 (22): 4135.
https://doi.org/10.1182/blood.V114.22.4135.4135
Published: 2009